Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
批准号:
10319171
负责人:
ERIN A. HAZLETT
金额:
$99.89万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-06 至 2024-12-31
关键词:
AgeAntipsychotic AgentsAttenuatedBrainBrain regionBrodmann&aposs areaClinicalClinical assessmentsCognitionCognitive deficitsCoupledDataDeteriorationDiagnosisDiagnosticDiffusion Magnetic Resonance ImagingDiseaseEtiologyEventFunctional Magnetic Resonance ImagingGeneticGoalsHospitalizationImpairmentIndividualInvestigationLinkLongitudinal StudiesMachine LearningMagnetic Resonance ImagingMeasuresModelingNeurobiologyNeurocognitionNeurocognitiveNeuropsychologyOnset of illnessOutcomePathogenesisPatientsPatternPerformancePersonality DisordersPharmaceutical PreparationsPhenotypePrefrontal CortexPsychosesResearch Domain CriteriaRestRiskRisk AssessmentRisk FactorsScanningSchizophreniaSchizotypal Personality DisorderSeveritiesShort-Term MemoryStructureSymptomsTemporal LobeTestingTimeTreatment FactorUrsidae Familybasecausal modelearly onsetfollow-upfrontal lobefunctional outcomesimprovedlongitudinal courselongitudinal designmorphogensmultimodal neuroimagingmultimodalityneural circuitneuroimagingnovel strategiespredictive modelingprotective factorsresilienceschizophrenia-spectrum disordersocial deficitswhite matter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Schizotypal personality disorder (SPD) is similar to schizophrenia (SZ), but with fewer and attenuated
abnormalities, thus representing an important yet understudied intermediate SZ-spectrum phenotype.
Examination of abnormalities in SPD will provide information regarding etiology, genetics, treatment and risk
factors associated with psychosis. Although individuals with SPD demonstrate marked temporal lobe
abnormalities that resemble SZ, we hypothesize that relative “sparing” or “functional enhancement” in the
frontal lobes (e.g., dorsolateral prefrontal cortex), may protect these individuals from frank psychosis and the
severe social and cognitive deficits typically observed in SZ. Studying SPD is powerful as antipsychotic
medication and hospitalization confounds observed in SZ are not present. Moreover, there is no study
examining neurobiological changes in the SZ-spectrum that incorporates individuals with SPD using a
longitudinal design as proposed here. This novel approach will help disentangle potential risk and protective
factors for psychosis in the SZ spectrum. This is the first longitudinal study to utilize multimodal MR imaging
and Research Domain Criteria (RDoC) approaches in SZ-spectrum disorders to identify aberrant neural
circuitry along a continuum from healthy controls (HCs) to SPD to SZ and examine changes in these measures
in relationship to impairments in symptom severity, neurocognition and functional outcome. We propose
studying three groups (80 in each) of demographically matched and rigorously diagnosed individuals (age 18-
40): HCs (no Axis I or personality disorder), unmedicated individuals with SPD (and no Axis I disorder), and
early-onset (first 2 years of illness) SZ patients at baseline, 9-, and 18-month follow-up. Measures assessing
frontal and temporal lobe integrity include multimodal MR imaging (structural MRI, DTI, resting-state fMRI, and
task-based fMRI with a nonverbal event related working-memory task; baseline and 18-months) and
neuropsychological assessment (all three timepoints). We will utilize dynamic causal modeling to test
competing neurobiological models involving abnormal frontotemporal connectivity in the SZ-spectrum and
machine learning approaches to integrate multimodal neuroimaging, neurocognitive, and clinical assessment
data. We focus on three specific aims: (1) Investigate the longitudinal course of frontal-temporal lobe/circuitry
abnormalities in the SZ-spectrum using multimodal MR imaging; (2) Investigate the longitudinal course of
neurocognition, clinical, and functional outcome in the SZ spectrum; (3) Determine which factor or combination
of factors differentiate groups in the SZ-spectrum to identify those that are associated with risk for and
protection from SZ using machine learning.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CSRD Research Career Scientist Award Application
-
批准号:10701136
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:ERIN A. HAZLETT
-
依托单位:
A Novel Cognitive Remediation Intervention Targeting Poor Decision-Making and Depression in Veterans at High Risk for Suicide: A Safe,Telehealth Approach During the COVID-19 Pandemic
-
批准号:10366431
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:ERIN A. HAZLETT
-
依托单位:
A Novel Cognitive Remediation Intervention Targeting Poor Decision-Making and Depression in Veterans at High Risk for Suicide: A Safe,Telehealth Approach During the COVID-19 Pandemic
-
批准号:10539275
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:ERIN A. HAZLETT
-
依托单位:
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
-
批准号:10542376
-
项目类别:
-
资助金额:$100.32万
-
财政年份:2020
-
负责人:ERIN A. HAZLETT
-
依托单位:
Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrum
-
批准号:10381940
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2020
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:10177966
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:10426091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:9892965
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
CSR&D Research Career Scientist Award Application
-
批准号:9551820
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neurobiology of Affective Instability in Veterans at Low and High Risk for Suicide
-
批准号:10311973
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neurobiology of Affective Instability in Veterans at Low and High Risk for Suicide
-
批准号:9892959
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:ERIN A. HAZLETT
-
依托单位:
Selecting Best Neuroleptic Treatment for Veterans with Schizophrenia
-
批准号:8392955
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ERIN A. HAZLETT
-
依托单位:
Selecting Best Neuroleptic Treatment for Veterans with Schizophrenia
-
批准号:8142659
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ERIN A. HAZLETT
-
依托单位:
Selecting Best Neuroleptic Treatment for Veterans with Schizophrenia
-
批准号:8277786
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION IN BORDERLINE PATIENTS
-
批准号:7953684
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2009
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION IN BORDERLINE PATIENTS
-
批准号:7718165
-
项目类别:
-
资助金额:$2.05万
-
财政年份:2008
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION REGULATION IN HEALTHY INDIVIDUALS
-
批准号:7718192
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2008
-
负责人:ERIN A. HAZLETT
-
依托单位:
NEURAL SUBSTRATES OF EMOTION IN BORDERLINE PATIENTS
-
批准号:7605350
-
项目类别:
-
资助金额:$2.61万
-
财政年份:2007
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neural Substrates of Emotion in Borderline Patients
-
批准号:7342829
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2006
-
负责人:ERIN A. HAZLETT
-
依托单位:
Neural Substrates of Emotion in Borderline Patients
-
批准号:7171852
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2006
-
负责人:ERIN A. HAZLETT
-
依托单位:
海外基金